Demonstrating Pharmaceutical Quality System Effectiveness and Driving Continual Improvement: Evidence-Based Risk...

Area of Science:

• Pharmaceutical quality management
• Process engineering
• Regulatory science

Background:

• Product knowledge and quality evolve throughout a product's lifecycle.
• Maintaining control and consistent quality requires continuous improvement and robust product lifecycle management.
• Current frameworks can be enhanced by integrating evidence-based risk reduction strategies.

Purpose of the Study:

• Introduce the concept of evidence-based risk reduction within continual improvement.
• Explore how to strengthen the link between product/process knowledge, risk-based controls, and innovation.
• Identify pathways to achieve regulatory relief and flexibility in post-approval changes and product lifecycle management.

Main Methods:

• Conceptual framework development for evidence-based risk reduction.
• Analysis of the interplay between scientific/risk-based approaches and quality system effectiveness.
• Literature review on product lifecycle management and regulatory change control.

Main Results:

• Evidence-based risk reduction offers a practical approach to link product knowledge, risk management, and continuous improvement.
• Effective application of science and risk-based concepts is crucial for enhancing control.
• Demonstrated effectiveness of the pharmaceutical quality system is key to achieving regulatory flexibility.

Conclusions:

• Implementing evidence-based risk reduction can strengthen product lifecycle management.
• Regulatory relief and flexibility are achievable through robust application of science and risk management principles.
• A well-demonstrated pharmaceutical quality system is fundamental for assuring a state of control and enabling innovation.